MktsMarkets

Repligen Corporation
NASDAQ: RGENKey statistics
RGEN News
Stories mentioning RGEN from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | ||||||||
| Cost of Goods Sold | 85,971 | 94,696 | 88,290 | 91,224 | 77,801 | 128,706 | 77,383 | 77,314 |
| Gross Profit | (85,971) | (94,696) | (88,290) | (91,224) | (77,801) | (128,706) | (77,383) | (77,314) |
| Operating Expenses | ||||||||
| Research & Development | 14,458 | 13,930 | 14,175 | 13,958 | 12,114 | 11,677 | 9,710 | 10,575 |
| Sales General & Admin | 76,536 | 74,912 | 73,663 | 71,227 | 70,706 | 60,474 | 75,610 | 65,481 |
| Total Operating Expenses | ||||||||
| Operating Income (Loss) | 15,940 | 17,868 | 16,825 | 13,896 | 6,578 | (36,501) | (7,832) | 5,469 |
| Interest Income | ||||||||
| Interest Expense | 4,981 | |||||||
| Other Expense | (750.00) | 403.00 | (804.00) | 3,502 | (286.00) | (4,527) | 3,104 | (215.00) |
| Pretax Income | 1,772 | 19,113 | 17,112 | 18,215 | 7,943 | (38,608) | (1,149) | 9,027 |
| Tax Provision | (6,561) | 5,826 | 2,201 | 3,349 | 2,113 | (4,739) | (495.00) | 3,314 |
| Net Income (Loss) | 8,333 | 13,287 | 14,911 | 14,866 | 5,830 | (33,869) | (654.00) | 5,713 |
| Earnings Per Share (Basic) | 0.15 | 237.27 | 0.27 | 0.26 | 0.10 | (604.80) | (0.01) | 0.10 |
| Earnings Per Share (Diluted) | 0.15 | 233.11 | 0.26 | 0.26 | 0.10 | (604.80) | (0.01) | 0.10 |
| Weighted Average Shares Outstanding (Basic) | 56,354 | 56.00 | 56.00 | 56.00 | 56,123 | 56.00 | 56.00 | 56.00 |
| Weighted Average Shares Outstanding (Diluted) | 56,666 | 57.00 | 57.00 | 57.00 | 56,558 | 56.00 | 56.00 | 56.00 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About RGEN
Repligen Corporation (NASDAQ: RGEN) is a stock listed on the Nasdaq Stock Market under the ticker symbol RGEN. It last traded at $178.94 (Nov 9, 2026, 4:00 PM ET), up 3.1% on the day. That gives Repligen a market capitalisation of $11.3B and a price-to-earnings ratio of 268.5.
Over the past 52 weeks RGEN has traded between $100.99 and $198.87.
Net income for the quarter ended Mar 31, 2026 was $8.3M.
| Quarter ended | Revenue | Net income |
|---|---|---|
| Mar 31, 2026 | — | $8.3M |
| Dec 31, 2025 | — | $13.3M |
| Sep 30, 2025 | — | $14.9M |
| Jun 30, 2025 | — | $14.9M |
From Repligen’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…